Back to Search
Start Over
Spatial and temporal analysis of invasive pneumococcal disease due to erythromycinresistant serotypes.
- Source :
-
Enfermedades infecciosas y microbiologia clinica (English ed.) [Enferm Infecc Microbiol Clin (Engl Ed)] 2023 Feb; Vol. 41 (2), pp. 92-98. Date of Electronic Publication: 2022 Jul 27. - Publication Year :
- 2023
-
Abstract
- Objectives: To study the spatio-temporal distribution of cases of invasive pneumococcal disease (IPD) due to serotypes resistant to erythromycin and its relationship with community consumption of macrolides and childhood vaccination coverage.<br />Methods: We selected IPD cases in adults over 59 years old, residents in the Community of Madrid (MC), notified in the period 2007-2016. The variables studied were obtained from the Vaccination Information Systems and the Pharmaceutical Service. The cut-off point (minimum inhibitory erythromycin concentration > 0.5 mg/L) of the EUCAST classification was used to define erythromycin resistant serotypes. We used JointPoint to estimate the incidence trends by erythromycin resistant serotypes included in the 13-valent vaccine (STPCV13) and not included in it (STnoPCV13). The association of these incidences with the community consumption of macrolides and vaccination coverage was made using Poisson models. Statistical scanning was used for the detection of temporal-spaces clusters of cases.<br />Results: 1936 cases were identified, of which 427 erythromycin resistant serotypes were identified. The incidence of all cases due to resistant serotypes was decreasing (AAPC: -5,40%). During the period studied, the incidence of cases due to erythromycin resistant STPCV13 was decreasing with an annual percentage change (APC): -13.8 and was inversely associated with childhood vaccination coverage (IRR 0.641), while that of cases due to erythromycin resistant STnoPCV13 was ascending (APC): 4.5; and was not associated with coverage. 1 cluster was detected by STnoPCV13 and none by STPCV13 after the date of inclusion of the 13-valent in the childhood vaccination calendar.<br />Conclusions: The decrease in IPD due to resistant STPCV13 was associated with an increase in childhood vaccination coverage. The presence of clusters due to STnoPCV13 after the date of inclusion of the 13-valent vaccine in the childhood vaccination calendar indicates serotypes replacement. The increase in cases of resistant STnoPCV13 could be related to the replacement of vaccine serotypes in nasopharyngeal colonization, facilitated by the consumption of macrolides still at high levels in MC.<br /> (Copyright © 2021 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.)
- Subjects :
- Adult
Humans
Middle Aged
Serogroup
Pneumococcal Vaccines
Heptavalent Pneumococcal Conjugate Vaccine
Serotyping
Anti-Bacterial Agents pharmacology
Erythromycin pharmacology
Macrolides pharmacology
Streptococcus pneumoniae
Pneumococcal Infections epidemiology
Pneumococcal Infections prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 2529-993X
- Volume :
- 41
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Enfermedades infecciosas y microbiologia clinica (English ed.)
- Publication Type :
- Academic Journal
- Accession number :
- 35907773
- Full Text :
- https://doi.org/10.1016/j.eimce.2022.07.001